For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. Featuring daily updates ...

After struggling for years, Lumen Technologies' stock skyrocketed in 2024. Here's our price prediction for the shares until ...

Major U.S. benchmarks finished Monday lower, with the Dow Jones Industrial Average edging down 0.09% to 48,416.56.

BitMine’s stock has been volatile recently amid sharp swings in the broader crypto space. The stock is trading within a 52-week range of $3.92 to $161. Analysts have the stock at a consensus buy ...

New York City-based Senvest Management fully exited its position in Bank OZK (NASDAQ:OZK) during the third quarter, reducing ...

Immuron stock fell on Wednesday alongside the release of new clinical trial data.

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) is among the cheap healthcare stocks to buy heading into 2026. As of December 7, Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) is a consensus Buy with all ...

Resmed RMD has received FDA clearance for Personalized Therapy Comfort Settings (“PTCS”), which will be marketed as Smart ...

Neogen Corporation NEOG is well-poised to gain in the coming quarters, thanks to its continued product development efforts that enhance its existing offerings and advance its business strategy. The ...

The oncology specialist's targeted therapies could improve thousands of lives.

Recent industry reports have highlighted past and projected rapid expansion in the DNA diagnostics and genomics markets, driven by liquid biopsies, direct-to-consumer testing, and personalized ...

If you are looking at Illumina and wondering whether today’s price really reflects its long term potential, you are not alone; this stock has gone from market darling to question mark and back again ...